Clarithromycin-adenine and related conjugates

Tetrahedron Letters

Volumn 47, Issue 12, 2006, Pages 1919-1922

  Esteban, Jorge ^a   Costa, Anna M ^a   Cruzado, M Carmen ^b   Faja, Montserrat ^a   García, Pilar ^b   Vilarrasa, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b ERCROS SA   (Spain)

Author keywords

Clarithromycin adenine chimeras; Erythromycin thymidine chimeras; Macrolide antibiotics; Oxazolidinone linked conjugates; Oxime linked conjugates

Indexed keywords

3' AMINO 3' DEOXYTHYMIDINE; ADENINE; ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; MACROLIDE; NUCLEIC ACID BASE; NUCLEOSIDE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; OXIME DERIVATIVE; THYMIDINE DERIVATIVE;

ARTICLE; CHIMERA; DRUG CONJUGATION; DRUG SYNTHESIS; MICROCOCCUS LUTEUS; NONHUMAN;

MICROCOCCUS LUTEUS;

EID: 32644473168     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.01.079     Document Type: Article

References (29)

1. T. Sunazuka, S. Omura, S. Iwasaki, and S. Omura S. Omura Macrolide Antibiotics: Chemistry, Biology and Practice 2nd ed. 2002 Academic Press, Elsevier Orlando 99 180
2. L. Katz, and G.W. Ashley Chem. Rev. 105 2005 499 527
3. Z. Ma, R.F. Clark, R. Brazzale, S. Wang, M.J. Rupp, L. Li, G. Griesgaber, S. Zhang, H. Yong, L. Tam Pham, P.A. Nemoto, D.T.W. Chu, J.J. Plattner, X. Zhang, P. Zhong, Z. Cao, A.M. Nilius, V.D. Shortridge, R. Flamm, M. Mitten, J. Meulbroek, P. Ewing, J. Alder, and Y.S. Or J. Med. Chem. 44 2001 4137 4156
4. D.T.W. Chu, J.J. Plattner, and L. Katz J. Med. Chem. 39 1996 3853 3874
5. C. Walsh, and G. Wright Chem. Rev. 105 2005 391 393
6. Reviews: L.F. Tietze, H.P. Bell, and S. Chandrasekhar Angew. Chem., Int. Ed. 42 2003 3996 4028
7. G. Mehta, and V. Singh Chem. Soc. Rev. 31 2002 324 334
8. F. Schlünzen, R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, and F. Franceschi Nature 413 2001 814 821
9. C. Agouridas, A. Denis, J. Auger, Y. Benedetti, A. Bonnefoy, F. Bretin, J.F. Chantot, A. Dussarat, C. Fromentin, S.G. D'Ambrieres, S. Lachaud, P. Laurin, O. Le Martret, V. Loyau, and N. Tessot J. Med. Chem. 41 1998 4080 4100
10. A. Denis, C. Agouridas, J.-M. Auger, Y. Benedetti, A. Bonnefoy, F. Bretin, J.F. Chantot, A. Dussarat, C. Fromentin, S.G. D'Ambrieres, S. Lachaud, P. Laurin, O.L. Martret, V. Loyau, N. Tessot, J.-M. Pejac, and S. Perron Bioorg. Med. Chem. Lett. 9 1999 3075 3080
11. R. Berisio, J. Harms, F. Schluenzen, R. Zarivach, H.A.S. Hansen, P. Fucini, and A. Yonath J. Bacteriol. 185 2003 4276 4279
12. Y.S. Or, R.F. Clark, S. Wang, D.T.W. Chu, A.M. Nilius, R.K. Flamm, M. Mitten, P. Ewing, J. Alder, and Z. Ma J. Med. Chem. 43 2000 1045 1049
13. For reports of 9-oxime derivatives with good antibacterial activity, see: J.F. Chantot, A. Bryskier, and J.C. Gasc J. Antibiot. 39 1986 660 668
14. A. Denis, J.-M. Pejac, F. Bretin, and A. Bonnefoy Bioorg. Med. Chem. 11 2003 2389 2394
15. Y. Kawashima, Y. Yamada, T. Asaka, Y. Misawa, M. Kashimura, S. Morimoto, T. Ono, T. Nagate, and K. Hatayama Chem. Pharm. Bull. 42 1994 1088 1096
16. N. Akemi, K. Narita, S. Ohmoto, Y. Takahashi, S. Yoshizumi, T. Yoshida, N. Kada, E. Okezaki, and H. Kato Chem. Pharm. Bull. 49 2001 1120 1127
17. This ring is known to enhance antibacterial activity against resistant pathogens, by increasing the conformational rigidity of the macrolactone. See: W.R. Baker, J.D. Clark, R.L. Stephens, and K.H. Kim J. Org. Chem. 53 1988 2340 2345
18. P.B. Fernandes, W.R. Baker, L.A. Freiberg, D.J. Hardy, and E.J. MacDonald Antimicrob. Agents Chemother. 33 1989 78 81
19. For ketolides with heteroaromatic appendages (including two examples with adenine) linked via a thioether, see: D. Hunziker, P.-C. Wyss, P. Angehrn, A. Mueller, H.-P. Marty, R. Halm, L. Kellenberger, V. Bitsch, G. Biringer, W. Arnold, A. Stämpfli, A. Schmitt-Hoffmann, and D. Cousot Bioorg. Med. Chem. 12 2004 3503 3519
20. A.M. Costa, and J. Vilarrasa Tetrahedron Lett. 41 2000 3371 3375
21. R.R. Wilkening, R.W. Ratcliffe, G.A. Doss, K.F. Bartizal, A.C. Graham, and C.M. Herbert Bioorg. Med. Chem. Lett. 3 1993 1287 1292
22. J. Esteban, A.M. Costa, F. Urpí, and J. Vilarrasa Tetrahedron Lett. 45 2004 5563 5567
23. J. Esteban, Master Thesis, Universitat de Barcelona, 2002.
24. Wilkening, R. R. EP 0,503,932 A1, 1992.
25. 2), 45.2 (C2), 49.4 (3″-OMe), 50.2 (6-OMe), 65.4 (C3′), 65.6 (C5″), 68.6 (C5′), 70.5 (C11), 71.1 (C2′), 72.7 (C3″), 74.8 (C12), 76.6 (C13), 78.0 (C4″), 78.6 (C6), 78.9 (C3), 80.5 (C5), 96.1 (C1″), 102.8 (C1′), 167.1 (C9), 175.9 (C1).
26. J.M. McGill, and R. Johnson Magn. Res. Chem. 31 1993 273 277
27. The assays were performed in accordance with the Code of Federal Regulations guidelines: CFR Title 21, Part 436105.
28. Z.-Q. Xu, Y.-L. Qiu, S. Chokekijchai, H. Mitsuya, and J. Zemlicka J. Med. Chem. 38 1995 875 882
29. Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF, Alabama, USA), cf. http://www.taacf.org.